Article Details
Retrieved on: 2024-10-29 20:28:52
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Woodline Partners, highlighting its success in market-neutral strategies and biopharma sector investments compared to other hedge funds. The firm leverages alternative investment strategies to outperform benchmarks like the S&P 500.
Article found on: www.institutionalinvestor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here